Two lot numbers of dexmedetomidine hydrochloride (Precedex) 200 mcg/50 ml injection have been recalled by Fresenius Kabi USA due to the potential of lidocaine contamination. Administration of dexmedetomidine hydrochloride with lidocaine contamination to patients with lidocaine allergies can lead to a life threatening anaphylactic reaction. The company is recalling the following two lot numbers: 6121853 and 6122207. Dexmedetomidine hydrochloride 200 mcg/50 ml injection is labeled for sedation before or during surgical and other procedures in non-intubated patients.
All distributors and customers should quarantine and stop using the affected lots. All the product can be returned directly to Fresenius Kabi. Customers can reach out to the company directly if they have any questions or concerns at 1-866-716-2459 Monday-Friday, 8:00 am-5:00 pm Central Time.
Additional information is available at the following links: